-
Symposium will focus on how dietitians and diabetes educators can support patients on GLP-1-based therapies
Maureen Chomko, RDN, CDCES, and Colleen Dawkins, FNP-C, RDN, CSOWM, will explain how dietitians and diabetes educators can help screen patients for their eligibility for these drugs, educate patients on how to take these medications, and help them understand cost implications.
-
Panel to explore evidence and provide recommendations for using ‘Category X’ diabetes drugs during pregnancy
Ira J. Goldberg, MD, and other experts will review diabetes medications that have been associated with fetal complications and current recommendations for their discontinued use during pregnancy, despite significant maternal benefits outside of pregnancy.
-
Investigators to share results from Part 1 of CATALYST study of hypercortisolism in type 2 diabetes
Investigators including John B. Buse, MD, PhD, will present findings from a study of the prevalence of hypercortisolism in patients with an A1C of ≥7.5% despite receiving multiple standard-of-care therapies.
-
Symposium to discuss how primary care providers can elevate their practice for patients with diabetes
An ADA Primary Care Council symposium, featuring experts including Pamela Stamm, PharmD, BCPS, BCACP, CDCES, FASHP, FCCP, aims to help practitioners identify ways they can deliver more consistent, high-quality care in order to improve outcomes, reduce complications, and decrease hospitalizations.
-
Experts to debate roles of immune cells and beta-cells in driving progression of type 1 diabetes
Jamie L. Felton, MD, will make the case that immune cells play a more significant role in type 1 diabetes progression, while Edward A. Phelps, PhD, will take the position that beta-cells are more active participants in disease progression.
-
Researchers to explain the association between GLP-1 receptor agonists and severe side effects in obesity treatment
Daniel J. Drucker, MD, and other panelists will discuss the relative risks and strategies for mitigating the severe side effects of GLP-1 receptor agonists, among them pancreatitis.
-
Presenter Profiles: Liver Health in Diabetes
Kenneth Cusi, MD, and Karen D. Corbin, PhD, RD, preview a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Friday, June 21, at 5:30 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: Consensus or Controversy? Hot Topics in Nutrition 2024
Katherine Appleton, PhD, RNutr, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Friday, June 21, at 3:45 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: Diabetic Retinopathy Care and Screening—Is Artificial Intelligence Changing the Future?
Aaron Y. Lee, MD, MSCI, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Saturday, June 22, at 3:15 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profiles: Metformin Reexamined—Pleiotropic Effects in Mother and Offspring in Humans and Animal Models
Stephanie R. Wesolowski, PhD, and Maureen Gannon, PhD, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Sunday, June 23, at 8:00 a.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.